FIELD: medicine.
SUBSTANCE: haemoglobin and serum iron are measured in the patients. If the haemoglobin level is less than 140 g/l in males and 130 g/l in females, whereas the serum iron is less than 8.95 mcmole/l, an anti-anaemic therapy with Epocrin and Sorbifer is additionally prescribed. Epocrin is administered continuously by fractions in a dose of 25 International units/kg, subcutaneously six times a week. Sorbifer durules is administered in a dose of 200 mg a day. The therapeutic course makes three months.
EFFECT: invention ensures prolonged support of erythropoiesis and avoided complications.
1 tbl, 2 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD OF TREATING PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE AND ISCHEMIC HEART DISEASE WITH CARDIAC FAILURE COMPLICATED WITH ANAEMIA | 2012 |
|
RU2485960C1 |
METHOD FOR DETERMINING DEGREE OF SEVERITY OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE | 2012 |
|
RU2516971C1 |
METHOD FOR TREATING CHRONIC POSTHEMORRHAGIC ASIDEROTIC ANEMIA IN WOMEN OF PUBERTY AGE HAVING UTERINE HEMORRHAGES | 2006 |
|
RU2318524C2 |
METHOD OF TREATING ANAEMIA IN PREGNANT WOMEN | 2010 |
|
RU2445966C1 |
METHOD OF TREATING ANAEMIA IN PREGNANT WOMEN | 2013 |
|
RU2532387C1 |
METHOD OF TREATMENT OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE | 2016 |
|
RU2609274C1 |
METHOD FOR DETERMINING DEGREE OF SEVERITY OF AGGRAVATED CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) FOR SPECIFYING OPTIMAL APPROACH TO PATIENT MANAGEMENT | 2011 |
|
RU2467685C2 |
METHOD OF PREDICTING FREQUENCY OF EXACERBATIONS OF CHRONIC OBSTRUCTIVE LUNG DISEASE | 2011 |
|
RU2484770C2 |
METHOD FOR TREATING UTERINE HEMORRHAGE PATIENTS OF PUBERTY AGE FOR CHRONIC POST-HEMORRHAGIC ASIDEROTIC ANEMIA | 2006 |
|
RU2318536C2 |
METHOD FOR IMPROVEMENT OF SPUTUM EXPECTORATION | 2016 |
|
RU2609992C1 |
Authors
Dates
2016-03-10—Published
2014-11-13—Filed